634913-40-9

Basic information

• Product Name: C₁₅H₈ClF₆NO₅P^(1-)*Na⁽¹⁺⁾
• Synonyms: C₁₅H₈ClF₆NO₅P^(1-)*Na⁽¹⁺⁾
• CAS NO: 634913-40-9
• Molecular Weight: 485.639
• Mol File: 634913-40-9.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: C₁₅H₈ClF₆NO₅P^(1-)*Na⁽¹⁺⁾(CAS DataBase Reference)
• NIST Chemistry Reference: C₁₅H₈ClF₆NO₅P^(1-)*Na⁽¹⁺⁾(634913-40-9)
• EPA Substance Registry System: C₁₅H₈ClF₆NO₅P^(1-)*Na⁽¹⁺⁾(634913-40-9)

Safety Data

• Hazardous Substances Data: 634913-40-9(Hazardous Substances Data)

Upstream product

• 634913-39-6 2-{[3,5-bis(trifluoromethyl)phenyl]carbamoyl}-4-chlorophenyl dihydrogen phosphate 
• 328-74-5 3,5-Bis-(trifluoromethyl)aniline 
• 321-14-2 5-chloro-2-hydroxybenzoic acid 
• 634913-38-5 C₂₉H₂₁ClF₆NO₅P 
• 978-62-1 N-(3,5-bistrifluoromethylphenyl)-5-chloro-2-hydroxybenzamide 

Relevant articles and documents

O-SUBSTITUTED HYDROXYARYL DERIVATIVES

A medicament having inhibitory activity against NF-κB activation which comprises as an active ingredient a substance selected from the group consisting of a compound represented by the following general formula (I) and a pharmacologically acceptable salt thereof, and a hydrate thereof and a solvate thereof: wherein X represents a connecting group whose number of atoms in a main chain is 2 to 5 (said connecting group may be substituted), "A" represents an acyl group which may be substituted, (provided that unsubstituted acetyl group and unsubstituted acryloyl group are excluded,) or a C1 to C6 alkyl group which may be substituted, or A may bind to connecting group X to form a cyclic structure which may be substituted, "E" represents an aryl group which may be substituted or a heteroaryl group which may be substituted, ring Z represents an arene which may have one or more substituents in addition to the group represented by formula -O-A wherein A has the same meaning as that defined above and the group represented by formula -X-E wherein each of X and E has the same meaning as that defined above, or a heteroarene which may have one or more substituents in addition to the group represented by formula -O-A wherein A has the same meaning as that defined above and the group represented by formula -X-E wherein each of X and E has the same meaning as that defined above.